# Efficacy Study of Daily Administration of VPA in Patients Affected by Wolfram Syndrome

> **NCT04940572** · PHASE2 · UNKNOWN · sponsor: **Centre d'Etude des Cellules Souches** · enrollment: 23 (estimated)

## Conditions studied

- Wolfram Syndrome

## Interventions

- **DRUG:** Depakine

## Key facts

- **NCT ID:** NCT04940572
- **Lead sponsor:** Centre d'Etude des Cellules Souches
- **Sponsor class:** OTHER
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** UNKNOWN
- **Start date:** 2021-11-26
- **Primary completion:** 2025-11-01
- **Final completion:** 2025-12-01
- **Target enrollment:** 23 (ESTIMATED)
- **Last updated:** 2023-11-28

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT04940572

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT04940572, "Efficacy Study of Daily Administration of VPA in Patients Affected by Wolfram Syndrome". Retrieved via AI Analytics 2026-06-09 from https://api.ai-analytics.org/clinical/NCT04940572. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*